1. Science and regulation. FDA's approach to regulation of products of nanotechnology;Hamburg;Science,2012
2. Guidance for industry (Draft guidance): Drug products, including biological products, that contain nanomaterials, (2017).
3. Guidance for Industry. Developing medical imaging drug and biological products. Part 1: Conducting safety assessments, 2004.
4. FDA, Public safety notification on exosome products, 2019. https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/public-safety-notification-exosome-products.
5. Engineering precision nanoparticles for drug delivery;Mitchell;Nat. Rev. Drug Discov.,2021